#32026R1421EU extends approval periods for 20 pesticide active substances
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation extends the EU approval periods for 20 active substances used in plant protection products while renewal reviews are still underway. The substances include bensulfuron, deltamethrin, lambda-cyhalothrin, MCPA, metaldehyde, tebuconazole and others. The practical effect is that pesticide products containing these substances can remain on the market for longer, subject to existing conditions, while regulators finish their assessments. Farmers, pesticide manufacturers, distributors and national approval authorities should track the new expiry dates and any later renewal decisions.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Extends EU approval periods for 20 active substances used in plant protection products.
- Keeps existing approvals in place while renewal evaluations are still pending.
- Updates Implementing Regulation (EU) No 540/2011 with revised approval timelines.
Obligations
What this law requires
National plant protection product approval authorities should continue applying the existing approval conditions for products containing the listed active substances while the EU renewal evaluations remain pending and the approval periods are extended.
Manufacturers and authorization holders of plant protection products containing bensulfuron, benzovindiflupyr, chlorotoluron, clethodim, cycloxydim, cymoxanil, dazomet, deltamethrin, diclofop, fenazaquin, fluopicolide, hymexazol, lambda-cyhalothrin, MCPA, MCPB, metaldehyde, metsulfuron-methyl, paclobutrazol or tebuconazole should track the extended EU approval periods and any later renewal decisions affecting continued marketing.
Distributors and users placing plant protection products containing the listed active substances on the market should ensure those products remain subject to the existing approval and authorization conditions during the extended approval period.